John Johnson

John Johnson

Président chez VERASTEM, INC.

Fortune : 8 M $ au 30/09/2026

68 ans
Health Technology
Commercial Services
Consumer Services

Profil

Mr. John H.
Johnson
is an Operating Partner at Healthquest Capital Management Co LLC, an Independent Non-Executive Director at Xeris Biopharma Holdings, Inc., an Independent Director at Axogen, Inc., an Independent Chairman at Verastem, Inc., an Executive Chairman at VirMedica, Inc., a Chairman at Cortendo AB, a Principal at Plum Brook Advisors LLC and an Operating Advisor at Cobepa North America, Inc. He is on the Board of Directors at Xeris Biopharma Holdings, Inc., Axogen, Inc., Cempra Pharmaceuticals, Inc. and Mirata Pharmaceuticals LLC.
Mr. Johnson was previously employed as an Executive Chairman by Applied Therapeutics, Inc., a Chief Executive Officer & Director by Reaction Biology Corp., a Non-Executive Chairman by Autolus Therapeutics Plc, a Chief Executive Officer & Director by Strongbridge Biopharma Plc, a Chairman by Corcept Therapeutics, Inc., a Lead Independent Director by Sucampo Pharmaceuticals LLC, an Independent Director by Portola Pharmaceuticals LLC, an Independent Director by Histogenics Corp., a Member-Health Section Governing Board by Biotechnology Industry Organization, a Chief Executive Officer-Emeritus by Dendreon Corp., a President, Chief Executive Officer & Director by Savient Pharmaceuticals, Inc., a Chairman by Tranzyme Pharma, Inc. (Canada), a Chairman by OCERA Therapeutics LLC, an Independent Director by Cempra, Inc., a President-Oncology Unit by Eli Lilly & Co., a Chief Executive Officer & Director by ImClone Systems, Inc., a President by Ortho Biotech Products LP, a Vice President by CNS Pharmaceuticals, Inc.,

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/06/2026 707 276 ( 0,39 % ) 7 M $ 30/09/2026
24/06/2026 14 150 ( 0,03 % ) 593 168 $ 30/09/2026
21/05/2026 52 666 ( 0,06 % ) 423 961 $ 30/09/2026

Postes actifs de John Johnson

SociétésPosteDébut
VERASTEM, INC. Président 15/12/2025
AXOGEN, INC. Directeur/Membre du Conseil 19/07/2021
XERIS BIOPHARMA HOLDINGS, INC. Directeur/Membre du Conseil 05/10/2021
Fondateur 01/08/2014
Président 09/11/2015
Directeur/Membre du Conseil -
Consultant / Advisor -
Private Equity Investor 01/01/2023
Président 17/03/2015
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░

Anciens postes connus de John Johnson

SociétésPosteFin
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de John Johnson

Formation de John Johnson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

79

Relations au 1er degré

41

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées41

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Technology Services

Commercial Services

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Tranzyme Pharma, Inc. (Canada)

Health Technology

Health Technology

Commercial Services

Commercial Services

Finance

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. John Johnson
🔇